Compare Tango Therapeutics Inc. (TNGX) vs Western Digital Corp (WDC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tango Therapeutics Inc. vs Western Digital Corp — how do they compare? Tango Therapeutics Inc. trades at $22.5 (market cap $3.74B), while Western Digital Corp trades at $347.69 (market cap $136.29B). The key difference: Western Digital Corp is far larger — about 36.4× Tango Therapeutics Inc.'s market cap, and Western Digital Corp pays a 0.16% dividend while Tango Therapeutics Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Tango Therapeutics Inc. for 0 Days and Western Digital Corp for 38 Days on average.
| TNGX | WDC | |
|---|---|---|
Market Cap | $3.74B | $136.29B |
Volume | 3,438,781 | 6,718,334 |
Sector | Health | Technology |
52-Week High | $32.90 | $746.23 |
52-Week Low | $7.50 | $120.44 |
Typical Hold Time | 0 Days | 38 Days |
Enterprise Value | $2.76B | $135.76B |
Dividend Yield | — | 0.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Western Digital (WDC) trades at $380.71, down 1.61% amid recent volatility. The stock shows strong fundamentals with a P/E of 14.14, net income margin of 71.97%, and three consecutive quarterly EPS beats. Technicals are bearish with support at $378, but oversold RSI levels suggest potential rebound. Recent news highlights AI-driven demand for high-capacity drives but also competitive threats from Toshiba's expansion plans.
Outlook remains positive long-term due to robust earnings growth and AI infrastructure tailwinds, though near-term risks include increased competition and pricing pressure. Analyst consensus is strongly bullish with a $643 price target, indicating 69% upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →About Western Digital Corp
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →
